Table 3 Causes of albumin and pantoprazole disapproval within the intervention period
Albumin | Pantoprazole | ||
|---|---|---|---|
Cause of disapproval | Number (%) | Cause of disapproval | Number (%) |
Management of edema in patients with serum albumin level above 2 g/dL | 73 (24.58) | Ability to tolerate an oral PPI | 246 (53.02) |
A component of parenteral nutrition | 59 (19.87) | Presence of only one minor risk factor for stress-related mucosal damage prophylaxis | 115 (24.78) |
Monotherapy of edema without a loop diuretic | 36 (12.12) | Treatment of acute pancreatitis | 29 (6.25) |
Therapeutic paracentesis with ascitic fluid removal less than 5 L | 21 (7.07) | Treatment of acute cholangitis or cholecystitis | 21 (4.53) |
Monotherapy of hepatorenal syndrome without a vasoactive agent | 17 (5.72) | Gastric and/or pancreas cancer | 17 (3.66) |
Prolonged prevention (more than 2 weeks) of cerebral vasospasm in patients with subarachnoid hemorrhage | 11 (3.7) | Lower GI obstruction or bleeding | 15 (3.23) |
Non-ARDS condition | 3 (1.01) | Non-refractory (mild) dyspepsia | 9 (1.94) |
Others (no specific explanation) | 42 (14.14) | Others (no specific explanation) | 12 (2.59) |